Skip to content
PIL Logo

Levitra 10 mg orodispersible tablets

Last Updated on eMC 26-Sep-2016 View document  | Bayer plc Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 26-Sep-2016 and displayed until Current

Reasons for adding or updating:

  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Change to section 3 - how to take/use

Updated on 23-Dec-2015 and displayed until 26-Sep-2016

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision

Updated on 03-Jun-2014 and displayed until 23-Dec-2015

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 07-Apr-2014 and displayed until 03-Jun-2014

Reasons for adding or updating:

  • Change to other sources of information section

Updated on 25-Apr-2013 and displayed until 07-Apr-2014

Reasons for adding or updating:

  • Change to section 4 - possible side effects

Updated on 22-Jun-2012 and displayed until 25-Apr-2013

Reasons for adding or updating:

  • Updates to formatting

Updated on 02-Apr-2012 and displayed until 22-Jun-2012

Reasons for adding or updating:

  • Change to date of revision
  • Correction of spelling/typing errors

Updated on 12-Mar-2012 and displayed until 02-Apr-2012

Reasons for adding or updating:

  • Change to date of revision

Updated on 23-Aug-2011 and displayed until 12-Mar-2012

Reasons for adding or updating:

  • Change to date of revision
  • Change to Marketing Authorisation Holder

Updated on 15-Aug-2011 and displayed until 23-Aug-2011

Reasons for adding or updating:

  • Change to date of revision

Updated on 10-Jun-2011 and displayed until 15-Aug-2011

Reasons for adding or updating:

  • Change to Further Information section
  • Change to manufacturer contact details

Updated on 18-Mar-2011 and displayed until 10-Jun-2011

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Company image
Address

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA

Fax

+44 (0)1635 563 393

Telephone

+44 (0)1635 563 000

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

vardenafil hydrochloride

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue